The largest database of trusted experimental protocols

Gemcitabine hcl

Manufactured by Selleck Chemicals
Sourced in United States, China

Gemcitabine HCl is a chemical compound used as a laboratory reagent. It is a hydrochloride salt of the nucleoside analog gemcitabine, which is commonly used in cancer research and development. The product is supplied as a white to off-white crystalline powder.

Automatically generated - may contain errors

6 protocols using gemcitabine hcl

1

Anticancer Drug Screening in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
MiaPaCa2, MDA-MB231, Panc1, AsPC1, and HEK293T cell lines were obtained from American Type Culture Collection (ATCC) and mycoplasma-free. These cells were cultured in Dulbecco’s minimal essential medium (DMEM) from Nacalai (California, USA) supplemented with 10% v/v FBS and penicillin (100 U/mL)/streptomycin (100 μg/mL) from Hyclone (IL, USA). Antibodies for GAPDH (14C10, #2118), phospho-AKT Ser473 (#9271), phospho-ERK Thr202/Tyr204 (#9101), phospho-S6 Ser235/236 (#2211), YAP (#4912), phospho-YAP Ser127 (#4911), and phospho-LATS1 Ser909 (#9157) were from Cell Signaling Technology (MA, USA). Antibody for TAZ (#HPA007415) was from Sigma-Aldrich (MO, USA). Gemcitabine-HCl (#S1149) was obtained from Selleck Chemicals (TX, USA), while doxorubicin-HCl (#D-4000) from LC Laboratories (MA, USA). PD184352, Triciribine and Rapamycin were obtained from Sigma-Aldrich (MO, USA). The Cell viability was assayed by colorimetric based CellTiter 96® AQueous One Solution Cell Proliferation kit (#G3581, Promega), per manufacture’s protocol.
+ Open protocol
+ Expand
2

Preparation and Formulation of Anticancer Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
For in vitro studies, 6-thio-dG (Metkinen Oy, Kuopio, Finland) was dissolved in DMSO/water (1:1) to prepare 10 mM stock solutions, which were kept frozen at −20°C. A 1 mM, final concentration stock was prepared for in vitro experiments and added in fresh medium at different concentrations. Erlotinib HCl (Selleckchem, Houston, TX) was dissolved in DMSO to prepare 10 mM stock solutions, which were kept frozen at −80°C. A 2.5 μM erlotinib final concentration was used for in vitro experiments. Osimertinib and paclitaxel (Selleckchem) were dissolved in DMSO, and carboplatin (Selleckchem) was dissolved in water to prepare 10 mM stock solutions, which were kept frozen at −80°C. A 1 mM final concentration stock was prepared for in vitro experiments and added in fresh medium at different concentrations.
For mouse in vivo studies, 6-thio-dG was prepared in 5% DMSO for intraperitoneal (i.p.) injection or 0.4% (hydroxypropyl)methyl cellulose (Sigma, Saint Louis, MO) for oral gavage. Erlotinib was prepared in 15% Captisol (β-cyclodextrin, sulfobutyl ethers, sodium salts) (Cydex Pharmaceuticals, Lawrence, KS) for oral gavage. Gemcitabine HCl and cisplatin (Selleckchem) were dissolved in 0.9% NaCl saline solution for i.p. injections.
+ Open protocol
+ Expand
3

AZD1775 and Gemcitabine HCL Storage

Check if the same lab product or an alternative is used in the 5 most similar protocols
AZD1775 and gemcitabine HCL were purchased from Selleck Chem. The drugs were reconstituted in dimethyl sulfoxide (DMSO) and stored at −20ºC. In each experiment, an equivalent amount of DMSO for the highest drug concentration was used as vehicle/control.
+ Open protocol
+ Expand
4

Brusatol and Gemcitabine Combination Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brusatol was purchased from Tauto Biotech (E-1044; Shanghai, China). Gemcitabine HCl for the in vitro experiments was purchased from Shanghai Boyun Biotech Co. Ltd. (BY13174; Shanghai, China), and Gemcitabine HCl for the in vivo experiments was purchased from Selleck Chemicals (S1149; Houston, TX, USA). The antibodies used in this study were against Keap1 (AF5266), MDR1 (AF5185), and MRP5 (DF7149) (Affinity Biosciences, OH, USA); Nrf2 (ab62352), NQO1 (ab80588), HO-1 (ab68477), active caspase-3 (ab2302), and Ki-67 (ab16667) (Abcam Inc., MA, USA); and GAPDH (5174S), Bax (2772S), and Bcl-2 (15071S) (Cell Signaling Technology Inc., MA, USA). Brusatol and Gemcitabine HCl were dissolved in DMSO and then added to medium to a certain concentration while limiting the DMSO concentration to below 0.1%.
+ Open protocol
+ Expand
5

Anticancer Drug's Effects on Tumor–Stroma Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyze the effects of anticancer drugs on tumor–stroma cross talk, we performed the same experiments by treating the cells with gemcitabine. To this aim, gemcitabine HCl (supplied by Selleckchem) was diluted in DMEM (or in L15 medium just before confocal laser scanning microscopy) at 5 μM final concentration.
+ Open protocol
+ Expand
6

Preparation and Formulation of Antineoplastic Agents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Clofarabine, Cladribine, Gemcitabine HCl, Triapine, Nelarabine, Cisplatin, and LB-100 were purchased from Selleck Chemical. BS-181 and PHA-767491 were purchased from MedChem Express. In vitro use: All compounds except for LB-100 and Cisplatin were reconstituted in DMSO, aliquoted, and stored at −80°C until use. LB-100 was reconstituted to 10 mM in sterile water, aliquoted, and stored at −20°C until use. Cisplatin was reconstituted to 3 mM in sterile saline and stored at 4°C until use. MTT was purchased from Research Products International and reconstituted to 5 mg/mL in sterile PBS, aliquoted, and stored at −20°C until use. In vivo formulation: Clofarabine was prepared for in vivo xenografts in 25% polyethylene glycol 400 (PEG400) (Sigma Aldrich 06855) in 0.9% sterile saline (USP Sterile Grade, Fisher Scientific Z1376).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!